ICU Stocktwits – Company, Data, & News
ICU Stocktwits
ICU stocktwits – ICU Medical, Inc. develops, manufactures, and sells innovative medical products in infusion therapy and critical care applications.
About ICU Company
Welcome to our dedicated SeaStar Medical Holding Corporation (ticker: ICU) news page, a resource for investors and traders seeking the latest updates and insights on SeaStar Medical Holding Corporation stock.
SeaStar Medical Holding Corporation (ICU) is a pioneering medical technology company focused on developing proprietary solutions to mitigate the negative impact of hyperinflammation on vital organs. The Company specializes in developing and commercializing extracorporeal therapies that specifically target effector cells responsible for systemic inflammation. This inflammation often leads to direct tissue damage and the secretion of pro-inflammatory cytokines that can trigger and maintain imbalanced immune responses.
SeaStar Medical’s core business revolves around innovative treatments to alleviate the intense inflammatory responses in various medical conditions. Their key product offerings include advanced renal therapy systems designed to reduce the impact of cytokine storms that often occur in severe infections and autoimmune diseases.
The Company’s notable accomplishments include successful clinical trials that have demonstrated the effectiveness of its therapies in reducing inflammation and improving patient outcomes. SeaStar Medical is currently involved in several research and development projects to expand the application of its therapies to multiple medical disciplines.
Financially, SeaStar Medical Holding Corp. is well-positioned with strategic partnerships that enhance its research capabilities and product distribution. The Company is committed to advancing its technology through continuous innovation and maintaining strong relationships with healthcare providers and patients.
For investors and shareholders, SeaStar Medical represents a promising opportunity in medical technology. Focusing on addressing critical health challenges through cutting-edge science and compassionate care.
ICU Stock Data
MARKET CAP: 36.48M
FLOAT: 4.17M
INSIDERS OWNERSHIP11.82%
INSTITUTIONS OWNERSHIP5.06%
SHORT PERCENT3.77%
INDUSTRY: Surgical and Medical Instrument Manufacturing
SECTOR: Manufacturing
WEBSITE: Link
COUNTRY: United States of America
CITY: DENVER
ICU Medical (ICUI) – Stocktwits Mentions
How Often Is ICU Medical Mentioned On StockTwits?
ICU Medical was mentioned an estimated one time in discussions on StockTwits yesterday.
Analyzing Stocktwits Mentions, How Is ICU Medical Performing Compared To Its Industry Peers?
ICU Medical underperforms its industry peers regarding Stocktwits Mentions, ranking in the 9th percentile.
What Does A High Frequency Of StockTwits Mentions Indicate For ICU Medical’s Market Sentiment?
A high frequency of mentions on StockTwits for ICU Medical could indicate strong market interest or sentiment towards the Company. It often reflects the trading community’s engagement with ICU Medical’s stock, potentially signaling bullish or bearish trends based on the context of the discussions.
How Often Does AltIndex Update Information On ICU Medical’s Mentions On StockTwits?
AltIndex updates the data on ICU Medical’s mentions on StockTwits daily. This frequent update schedule ensures investors can access the most current insights into market sentiment and discussion dynamics related to ICU Medical on the platform.
Similar Companies
Company: Stocktwits Mentions
DentsplyDentsplyXRAY: 0 0%
LeMaitre Vascular: 0 0%
iRhythm Technologies: 0 0%
NovoCure: 3 0%
Silk Road Medical: 1 0%
Align Technology (ALGN) Statistics & Alternative Data 2024
Align Technology Inc. designs, manufactures, and markets precise aligner therapy, intra-oral scanners, and CAD/CAM digital services in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.
Price | $220.45 |
Target Price | Sign up |
Volume | 11,90,000 |
Market Cap | $16.6B |
Year Range | $213.8 – $330.25 |
Dividend Yield | 0% |
PE Ratio | 37.43 |
Industry | Medical & Dental Instruments |
Dentsply (XRAY) Statistics & Alternative Data 2024
Dentsply Sirona Inc. is a designer, developer, manufacturer, and marketer of consumable dental products for the professional dental market. It also manufactures and markets other consumable medical device products.
Price | $26.41 |
Target Price | Sign up |
Volume | 17,50,000 |
Market Cap | $5.48B |
Year Range | $24.2 – $36.97 |
Dividend Yield | 2.42% |
PE Ratio | 22.28 |
Earnings Date | July 31 ’24 |
Industry | Medical & Dental Instruments |
LeMaitre Vascular (LMAT) Statistics & Alternative Data 2024
LeMaitre Vascular Inc. provides medical devices and human tissue cryopreservation services for treating peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
Price | $85.83 |
Target Price | Sign up |
Volume | 1,38,200 |
Market Cap | $1.93B |
Year Range | $51.83 – $90.34 |
Dividend Yield | 0.74% |
PE Ratio | 56.84 |
Earnings Date | August 1 ’24 |
Industry | Medical & Dental Instruments |
iRhythm Technologies (IRTC) Statistics & Alternative Data 2024
iRhythm is a digital healthcare company redefining how cardiac arrhythmias are clinically diagnos by combining our wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
Price | $88.34 |
Target Price | Sign up |
Volume | 7,50,490 |
Market Cap | $2.75B |
Year Range | $83.25 – $123.61 |
Dividend Yield | 0% |
Earnings Date | August 1 ’24 |
Industry | Medical & Dental Instruments |
NovoCure (NVCR) Statistics & Alternative Data 2024
NovoCure Limit, an oncology company, is engaged in developing, manufacturing, and commercializing Optune to treat various solid tumors. The Company markets Optune and Optune Lua, a Tumor Treating field transport system for monotherapy for adult glioblastoma patients.
Price | $19.02 |
Target Price | Sign up |
Volume | 11,70,000 |
Market Cap | $2.06B |
Year Range | $11.83 – $24.05 |
Dividend Yield | 0% |
Industry | Medical & Dental Instruments |
Silk Road Medical (SILK) Statistics & Alternative Data 2024
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm’s devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional. Approach of accessing the vascular system through the groin.
Price | $27.02 |
Target Price | Sign up |
Volume | 10,80,000 |
Market Cap | $1.07B |
Year Range | $8.09 – $27.09 |
Dividend Yield | 0% |
Industry | Medical & Dental Instruments |
Conclusion
Find the latest SeaStar Medical Holding Corporation (ICU) stock quote, history, news, and other vital information to help you with your stock trading.